Aurora Spine Appoints Executive Vice President of Sales
13 Febrero 2014 - 1:17PM
Marketwired
Aurora Spine Appoints Executive Vice President of Sales
CARLSBAD, CALIFORNIA--(Marketwired - Feb 13, 2014) - Aurora
Spine Corporation (TSX-VENTURE:ASG) announced today the appointment
of Mike Keegan to the newly created position of Executive Vice
President, U.S. Sales. Mr. Keegan will be responsible for the
Company's U.S. sales efforts, including the oversight of strategic
sales development, sales administration, adding divisional sales
directors and sales training. He will also serve as a member of
Aurora Spine's Executive Management Team.
Prior to joining Aurora, Mr. Keegan served as Director of U.S.
Sales for Lanx, a designer, manufacturer, and supplier of spinal
devices and biologics. Mr. Keegan has over 25 years of sales and
marketing experience.
Mr. Keegan served as Area Director for Globus Medical, District
Sales Manager for Medtronic and held various sales, marketing,
management and international roles with Boston Scientific
Corporation. Mr. Keegan began his sales career with the Xerox
Corporation. He has a proven track record of building dynamic and
highly successful sales teams. He received a B.A. degree from
Providence College and an MBA from Boston University.
Trent J. Northcutt, President and Chief Executive Officer, said,
"Mike Keegan's experience as a medical sales executive, with a
proven track record to create and lead successful and dynamic sales
teams, will be a tremendous asset to Aurora Spine. We believe his
background and extensive knowledge of the spine industry will allow
him to seamlessly integrate into this new role. Mike will focus on
further strengthening our sales and distribution network as we
continue to make rapid progress on the creation of a hybrid sales
force consisting of direct sales employees and independent
distributors. I am confident that Mike will lead our sales team to
maximum performance in 2014 and beyond."
About Aurora Spine
Aurora Spine is an early stage company focused on bringing new
solutions to the spinal implant market through a series of
innovative, minimally invasive, regenerative spinal implant
technologies.
Forward-Looking Statements
This news release contains forward-looking information that
involves substantial known and unknown risks and uncertainties,
most of which are beyond the control of Aurora Spine, including,
without limitation, those listed under "Risk Factors" and
"Cautionary Statement Regarding Forward-Looking
Information" in Aurora Spine's final prospectus (collectively,
"forward-looking information"). Forward-looking information in this
news release includes information concerning the proposed success
of the company's sales efforts. Aurora Spine cautions investors of
Aurora Spine's securities about important factors that could cause
Aurora Spine's actual results to differ materially from those
projected in any forward-looking statements included in this news
release. Any statements that express, or involve discussions as to,
expectations, beliefs, plans, objectives, assumptions or future
events or performance are not historical facts and may be
forward-looking and may involve estimates, assumptions and
uncertainties which could cause actual results or outcomes to
differ unilaterally from those expressed in such forward-looking
statements. No assurance can be given that the expectations set out
herein will prove to be correct and, accordingly, prospective
investors should not place undue reliance on these forward looking
statements. These statements speak only as of the date of this
press release and Aurora Spine does not assume any obligation to
update or revise them to reflect new events or circumstances.
Aurora Spine CorporationTrent NorthcuttPresident and Chief
Executive Officer(760) 424-2004Aurora Spine CorporationEric
FronkChief Financial Officer(760) 424-2004www.auroraspine.us
Aurora Spine (TSXV:ASG)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Aurora Spine (TSXV:ASG)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024